Cassava Sciences (SAVAW) Competitors

$0.43
-0.02 (-4.44%)
(As of 04/22/2024 ET)

SAVAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and CELUW

Should you be buying Cassava Sciences stock or one of its competitors? The main competitors of Cassava Sciences include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

Cassava Sciences vs.

180 Life Sciences (NASDAQ:ATNFW) and Cassava Sciences (NASDAQ:SAVAW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Cassava Sciences N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Cassava Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

180 Life Sciences and Cassava Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Cassava SciencesN/AN/A

In the previous week, Cassava Sciences' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Cassava Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Cassava SciencesN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Cassava Sciences tied by winning 0 of the 0 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SAVAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SAVAW vs. The Competition

MetricCassava SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$164.24M$4.71B$7.34B
Dividend YieldN/A3.48%5.49%3.98%
P/E RatioN/A236.80264.4620.33
Price / SalesN/A15,560.362,452.8483.30
Price / CashN/A11.3031.5127.23
Price / BookN/A5.294.564.22
Net IncomeN/A-$21.91M$101.37M$213.35M
7 Day Performance-50.57%0.42%-1.34%-0.42%
1 Month Performance-89.81%-4.12%-6.68%-5.10%
1 Year PerformanceN/A49.08%8.31%4.76%

Cassava Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-53.5%$0.00N/A0.004Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.11
flat
N/AN/A$0.00$253,573.000.002Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.21
flat
N/AN/A$0.00N/A0.00121Positive News
APLMW
Apollomics
0 of 5 stars
$0.03
+66.7%
N/A-73.4%$0.00N/A0.0059Gap Up
ARTLW
Artelo Biosciences
0 of 5 stars
$0.02
flat
N/A-79.2%$0.00N/A0.005Positive News
BCDAW
BioCardia
0 of 5 stars
$0.02
-34.5%
N/AN/A$0.00$477,000.000.0030Positive News
Gap Down
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.01
-9.8%
N/AN/A$0.00N/A0.0016Positive News
Gap Up
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.07
-21.2%
N/A-72.7%$0.00$17,065.000.007Positive News
Gap Down
High Trading Volume
CTCXW
Carmell
0 of 5 stars
$0.07
-35.5%
N/AN/A$0.00$3.73M0.009Positive News
CELUW
Celularity
0 of 5 stars
$0.03
-23.9%
N/A-61.1%$0.00$14.79M0.00225Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:SAVAW) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners